Blueweave
Global Antidiabetics Market Bwc20130

Global Antidiabetics Market Bwc20130

SPECIAL OFFER : 25% Super Discount For All !

Global Antidiabetics Market Size, By Product (Insulin {Rapid Acting, Long Acting, Premixed Insulin, Short-Acting, Intermediate Acting}, Drug Class {Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolidinedione}), By Patient Population (Pediatric, Adult, Geriatric), By Route of Administration (Insulin Syringe/Insulin Pen, Insulin Pump, Intravenous Infusion, Oral), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), Trend Analysis, Market Competition Scenario & Outlook, 2020-2026

  • Published Date: August 2020
  • Report ID: BWC20130
  • Available Format: PDF
  • Page: 175

Market Segmentation

By Product

Ø Insulin

ü Rapid Acting

ü Long Acting

ü Premixed Insulin

ü Short Acting

ü Intermediate Acting

Ø Drug Class

ü Alpha-Glucosidase Inhibitors

ü Biguanides

ü Sulphonylureas

ü GLP-1 Agonist

ü Meglitinides

ü DPP-4 Inhibitors

ü SGLT-2

ü Thiazolidinedione

 

By Patient Population

Ø Pediatric

Ø Adult

Ø Geriatric

By Route of Administration

Ø Insulin Syringe/Insulin Pen

Ø Insulin Pump

Ø Intravenous Infusion

Ø Oral

By Region

Ø North America

Ø Europe

Ø Asia Pacific

Ø South America

Ø Middle East & Africa